who takes bpc 157 BPC-157 - Peptide for Gut Health & Tissue Repair BPC-157 – Research Peptide |

The peptides for joint and tendon repair research overview covers the published mechanism evidence in detail

History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy

Originally derived from a partial sequence of a protein identified in human gastric juice, BPC-157 continues to serve as a well-characterized compound in peptide chemistry and analytical research

As steroids are illegal in most countries, BPC-157 may offer an effective means of improving muscle growth without recourse to steroids, although it is worth noting that the research on BPC-157 remains ongoing

Int J Mol Sci 2021, 22